These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34863146)

  • 1. Validation of the risk stratification score in idiopathic pulmonary fibrosis: study protocol of a prospective, multi-centre, observational, 3-year clinical trial.
    Manzetti GM; Hosein K; Cecchini MJ; Kwan K; Abdelrazek M; Zompatori M; Rogliani P; Mura M
    BMC Pulm Med; 2021 Dec; 21(1):396. PubMed ID: 34863146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment.
    Fisher JH; Al-Hejaili F; Kandel S; Hirji A; Shapera S; Mura M
    Respir Med; 2017 Apr; 125():65-71. PubMed ID: 28340864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
    Taha N; D'Amato D; Hosein K; Ranalli T; Sergiacomi G; Zompatori M; Mura M
    Respir Res; 2020 May; 21(1):119. PubMed ID: 32429952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Kramer MR
    Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Therapeutic Response to Pirfenidone in Idiopathic Pulmonary Fibrosis: Can We Do Better than with Forced Vital Capacity Alone?
    Hosein K; Le J; Mura M
    Lung; 2017 Feb; 195(1):101-105. PubMed ID: 27858160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 6-minute walk distance to predict lung transplant-free survival in fibrosing non-IPF interstitial lung diseases.
    Zanini U; Luppi F; Kaur K; Anzani N; Franco G; Ferrara G; Kalluri M; Mura M
    Respirology; 2024 May; 29(5):387-395. PubMed ID: 38320863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.
    Bodlet A; Maury G; Jamart J; Dahlqvist C
    Respir Med; 2013 Nov; 107(11):1781-8. PubMed ID: 24051272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
    Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
    Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, radiologic, and physiologic features of idiopathic pulmonary fibrosis (IPF) with and without emphysema.
    Li C; Wang Y; Liu Q; Zhang H; Xu F; Gao Z; Wang X; Tao G; Chen Y; Rong W; Yu H; Li F
    Expert Rev Respir Med; 2022 Jul; 16(7):813-821. PubMed ID: 35731004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-Year Survival in Patients with Idiopathic Pulmonary Fibrosis After Lung Transplantation.
    ten Klooster L; Nossent GD; Kwakkel-van Erp JM; van Kessel DA; Oudijk EJ; van de Graaf EA; Luijk B; Hoek RA; van den Blink B; van Hal PT; Verschuuren EA; van der Bij W; van Moorsel CH; Grutters JC
    Lung; 2015 Dec; 193(6):919-26. PubMed ID: 26404700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis.
    Mura M; Ferretti A; Ferro O; Zompatori M; Cavalli A; Schiavina M; Fabbri M
    Respiration; 2006; 73(4):495-502. PubMed ID: 16484770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.
    Serajeddini H; Rogliani P; Mura M
    Lung; 2018 Dec; 196(6):707-713. PubMed ID: 30151723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.
    Ryerson CJ; Hartman T; Elicker BM; Ley B; Lee JS; Abbritti M; Jones KD; King TE; Ryu J; Collard HR
    Chest; 2013 Jul; 144(1):234-240. PubMed ID: 23370641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
    Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
    BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
    Raghu G; Ghazipura M; Fleming TR; Aronson KI; Behr J; Brown KK; Flaherty KR; Kazerooni EA; Maher TM; Richeldi L; Lasky JA; Swigris JJ; Busch R; Garrard L; Ahn DH; Li J; Puthawala K; Rodal G; Seymour S; Weir N; Danoff SK; Ettinger N; Goldin J; Glassberg MK; Kawano-Dourado L; Khalil N; Lancaster L; Lynch DA; Mageto Y; Noth I; Shore JE; Wijsenbeek M; Brown R; Grogan D; Ivey D; Golinska P; Karimi-Shah B; Martinez FJ
    Am J Respir Crit Care Med; 2024 Mar; 209(6):647-669. PubMed ID: 38174955
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis.
    Lee H; Kim SY; Park YS; Choi SM; Lee JH; Park J
    Sci Rep; 2024 Apr; 14(1):8857. PubMed ID: 38632477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.